A Neutral Platform for Multi-Stakeholder Discussion in Oncology

The CDDF provides a neutral, multi-stakeholder platform designed to dismantle silos in oncology drug development and facilitate constructive dialogue. Operating as an independent facilitator, we ensure that discussion is driven by scientific progress and patient needs.

For regulators and HTA agencies, the CDDF’s unique forum offers a space where the voices of patients, academia, and industry are meaningfully integrated into a balanced and non-competitive environment. It also provides an ideal stage to share the latest regulatory updates and gather multi-stakeholder perspectives firsthand.

Engage with us to gain insights from multi-stakeholder discussions and stay informed on emerging trends in oncology drug development.

How CDDF Benefits Regulators/HTAs

To facilitate active participation in the CDDF multi-stakeholder community, the association offers complimentary registration for all regulatory and HTA representatives. By providing open access to the CDDF intranet—a comprehensive repository of meeting materials and publications—the CDDF supports regulators and HTA agencies in staying at the forefront of the evolving oncology landscape and gaining multi-stakeholder views.